3.5. Multivariate Competing Risk Models Analyses Show That CYCLON, NPM1 and R-IPI Are Prognostic Markers of Refractory Disease-Related Death in DLBCL. The gene discussed is CCDC86; the disease is diffuse large B-cell lymphoma.